Health insurance expenses linked to psychoactive medication prescribed outside of a diagnosed pathology in France in 2019, by medication type
(in million euros)
Medication type
Expense in million euros
-
-
-
-
-
-
-
-
The chart is not accessible to screen readers. Please switch to the table view to access the data.
You need a ÌÇÐÄÆƽâ°æ Account for unlimited access
In 2019, psychoactive drugs prescribed outside of a relevant diagnosis cost billions of euros to the French health insurance. During that year, roughly *** billion euros of expense related to antidepressants and mood regulators outside of a relevant diagnosis, such as depression. Antidepressants and mood regulators were thus the most expensive psychoactive drugs prescribed with no relevant diagnosis for the French health insurance, followed by anxiolytics.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
ÌÇÐÄÆƽâ°æ. (October 20, 2021). Health insurance expenses linked to psychoactive medication prescribed outside of a diagnosed pathology in France in 2019, by medication type (in million euros) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved August 07, 2026, from /statistics/1289907/expense-of-out-of-diagnosis-psychoactive-drugs-for-the-french-health-insurance/
ÌÇÐÄÆƽâ°æ. "Health insurance expenses linked to psychoactive medication prescribed outside of a diagnosed pathology in France in 2019, by medication type (in million euros)." Chart. October 20, 2021. ÌÇÐÄÆƽâ°æ. Accessed August 07, 2026. /statistics/1289907/expense-of-out-of-diagnosis-psychoactive-drugs-for-the-french-health-insurance/
ÌÇÐÄÆƽâ°æ. (2021). Health insurance expenses linked to psychoactive medication prescribed outside of a diagnosed pathology in France in 2019, by medication type (in million euros). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: August 07, 2026. /statistics/1289907/expense-of-out-of-diagnosis-psychoactive-drugs-for-the-french-health-insurance/
ÌÇÐÄÆƽâ°æ. "Health Insurance Expenses Linked to Psychoactive Medication Prescribed outside of a Diagnosed Pathology in France in 2019, by Medication Type (in Million Euros)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 20 Oct 2021, /statistics/1289907/expense-of-out-of-diagnosis-psychoactive-drugs-for-the-french-health-insurance/
ÌÇÐÄÆƽâ°æ, Health insurance expenses linked to psychoactive medication prescribed outside of a diagnosed pathology in France in 2019, by medication type (in million euros) ÌÇÐÄÆƽâ°æ, /statistics/1289907/expense-of-out-of-diagnosis-psychoactive-drugs-for-the-french-health-insurance/ (last visited August 07, 2026)
Health insurance expenses linked to psychoactive medication prescribed outside of a diagnosed pathology in France in 2019, by medication type (in million euros) [Graph], ÌÇÐÄÆƽâ°æ, October 20, 2021. [Online]. Available: /statistics/1289907/expense-of-out-of-diagnosis-psychoactive-drugs-for-the-french-health-insurance/
